Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-18

Clinical Trial Update: Accelerated HEmodiafiltration in Severe Acute Diquat (AHEAD) Poisoning [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating accelerated hemodiafiltration as a treatment for severe diquat poisoning; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Conditions: Diquat Poisoning | Phase 1 | Status: NOT_YET_RECRUITING